Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The short answer for Medicaid behavioral health operators
Strategic and payer-adjacent buyers will pay for multi-state Medicaid behavioral health scale again, but only when the licensure, contract, and compliance file survives a microscope. If your book is Medicaid-heavy and your diligence room is not built, the Clarvida process is the current benchmark for what buyers now demand.
Here are the facts. Molina Healthcare acquired Pathways Health and Community Support from Providence Service Corporation in 2015, then sold it to Atar Capital in October 2018. Molina disclosed that it “sold the business for a nominal purchase price” as part of a refocus on its health plan business. Atar rebranded the platform Clarvida. On May 7, 2026, Axios Pro first reported Atar was in the second round of a sale process, and Behavioral Health Business followed with detail: outpatient and telehealth care across 17 states, more than 4,600 employees, roughly 60,000 patients per year.
Why this trade matters. Founders and PE-backed CEOs sitting on a Medicaid-heavy outpatient or telehealth book in Texas, Ohio, North Carolina, or Arizona should read the diligence list, not the headline multiple. Commercial-pay residential SUD platforms got the multiple compression headlines. Medicaid outpatient and CCBHC-adjacent businesses were quieter, slower, and frankly harder for generalist PE to underwrite. That has changed.
What buyers will actually tear apart in diligence
Five things drive (or kill) Medicaid behavioral health valuations right now. They are not the same five that mattered in 2021.
- The multi-state licensure stack. A 17-state footprint sounds impressive until a buyer’s regulatory counsel maps every facility license, every clinic certification, every CCBHC designation, every telehealth registration, and every controlled-substance registration against renewal dates and open corrective action plans. Our team has watched deals retraded by $4 to $7 million because three state licenses in a 12-state platform were sitting on conditional status from the last survey window and nobody flagged it in the CIM. Buyers will pull every recent finding from state agencies like Texas HHSC, Ohio MHAS, and North Carolina DHHS. If your compliance file is not organized by state and by surveyor focus, you are not ready.
- Medicaid contract durability. Direct state contracts, MCO contracts, and CCBHC cost-based reimbursement each have very different durability profiles. Buyers model contract expiration cliffs, rate methodology changes, and the risk of state procurement re-bids.
- Payer concentration. If a single MCO is more than 20% of revenue in any state, expect a discount or an escrow. The MCO market is concentrated enough that this is a live risk. KFF reports that five for-profit, publicly traded companies (Centene, Elevance, UnitedHealth Group, Molina, and CVS Health) account for 50% of Medicaid MCO enrollment nationally. Lose one relationship, lose a state.
- Parity exposure. The 2024 MHPAEA final rule complicated NQTL analysis obligations. On May 15, 2025, the Departments of Labor, HHS, and Treasury issued a statement announcing they will not enforce the portions of the 2024 Final Rule that are new relative to the 2013 rule. As the Departments put it: “MHPAEA’s statutory obligations, as amended by the CAA, 2021, continue to have effect.” Buyers ask sellers to demonstrate that utilization management and network participation positions do not create downstream litigation or recoupment risk. Sellers rarely have this analysis ready.
- Compliance program maturity. 42 CFR Part 2, HIPAA, state-specific behavioral health confidentiality overlays, OIG work-plan items, and any active SIU audit activity. Buyers want the mock survey history, the internal audit cadence, and the remediation evidence. Not a policy binder.
What sellers must prepare to defend valuation
Sellers who clear diligence cleanly treat exit readiness as an 18 to 24 month exercise, not a 90-day data room sprint. Sellers who close well have done four things before they hire a banker.
- They keep a single source of truth for licensure across every state, with renewal calendars, surveyor history, and EOC tour readiness documented.
- They keep a Medicaid contract abstract for every MCO and state agreement, with rate methodology, timely filing rules, utilization management requirements, and termination provisions mapped.
- They keep an NQTL comparative analysis current against the statutory CAA 2021 requirement. Benefits counsel has confirmed that following the May 15, 2025 statement, the longstanding NQTL rule from the 2013 final rules, as well as the provisions of the Consolidated Appropriations Act, 2021, remain in force. The NQTL comparative analysis requirement went into effect on February 10, 2021 and continues to remain in effect.
- They run a chart audit program with documented findings, remediation, and a clean trend line over the trailing 24 months, with ASAM Criteria, 4th Edition level-of-care determinations reflected in the documentation for outpatient and intensive outpatient services.
Sellers who skip any of these renegotiate purchase price or accept indemnity escrows north of 15% of consideration. That is not a theoretical number. That is what our team has seen in two behavioral health transactions that closed in the last 14 months.
The buyer universe has changed, and so has enforcement risk
The Clarvida buyer pool tells you who is actually writing checks in this segment. It is not the 2021 generalist PE crowd. Strategics are building multi-state Medicaid platforms. Payer-adjacent buyers (including Medicaid MCO parents quietly building captive provider arms) are back at the table. And a smaller set of specialist sponsors with prior behavioral health operating experience will engage where they can absorb tuck-ins without licensure or EMR migration disasters.
They underwrite differently than the 2021 vintage. Strategics will pay for census stability, clinical leadership depth, and clean regulatory history. They will not pay for growth assumptions unsupported by infrastructure. Payer-adjacent buyers will pay for network coverage in specific states and for documented outcomes data tied to Medicaid quality measures. Specialist sponsors will pay for platforms that can absorb tuck-ins cleanly.
If your story to the market is “we grew 40% last year on a Medicaid book,” expect questions about how. Rapid Medicaid growth without a corresponding compliance and revenue integrity build-out is now a red flag, not a green one.
Enforcement history is why. Arizona is the case study every buyer’s counsel now cites. Attorney General Kris Mayes disclosed on May 14, 2026 that AHCCCS recorded approximately $3.1 billion in behavioral health billing in the American Indian Health Plan from 2021 to 2023, and that billing dropped to approximately $229,942,919 from 2024 to 2026, a 92% decline after her office launched enforcement in 2023. Mayes framed it directly: “For the past three years, my office has made it a top priority to hunt down and prosecute the criminals who stole from Arizona’s Medicaid program while exploiting some of our most vulnerable residents.” Since 2023, her office has indicted 140 people and businesses connected to the schemes and recovered or seized more than $139 million in cash and real estate.
DOJ picked up the thread federally. The 2025 National Health Care Fraud Takedown charged 324 defendants across 50 federal districts in connection with over $14.6 billion in intended loss, more than doubling the prior record. The government seized over $245 million in cash, luxury vehicles, cryptocurrency, and other assets, and CMS separately prevented over $4 billion in fraudulent claim payments in the months leading up to the takedown. Buyers now look for the absence of that kind of risk before they look at growth.
Where AHS fits, and an invitation
Atlantic Health Strategies works the sell-side and buy-side of behavioral health transactions as an operating advisor, not a banker. Our team builds the licensure stack documentation, runs the multi-state regulatory diligence, refreshes the NQTL comparative analysis, stands up the compliance program evidence, and sits next to founders and PE partners through the QofE and management presentations. When a buyer’s counsel asks about a 2022 finding in your Ohio outpatient clinic, we have the file open before the question finishes.
If you are 12 to 24 months from a process, the work starts now. If you are closer than that, we can still help, but every month of delay costs you negotiating room on price, escrow size, and indemnity caps.
If you want to talk about any of this in person, AHS is sponsoring the South Florida Behavioral Health Coffee Morning at Harvest Patio in Boca Raton. Come find me. Bring your hard questions about exit readiness, Medicaid contract risk, or whatever the buyer’s diligence list is keeping you up about. Coffee is on us.
Frequently asked questions
Why did Atar Capital’s sale of Clarvida matter to behavioral health operators?
It is the first clean signal in years that strategic and payer-adjacent buyers will pay for multi-state Medicaid outpatient scale, provided the licensure and compliance file holds up. Atar acquired Pathways from Molina in October 2018 for a nominal price (per Molina’s own disclosure), later rebranded it Clarvida, and per Axios Pro and Behavioral Health Business entered a second-round sale process in May 2026 with more than 4,600 employees and around 60,000 patients across 17 states. That combination of Medicaid concentration, multi-state licensure, and a real buyer pool is the current benchmark for a Medicaid behavioral health exit.
Which Medicaid behavioral health diligence issues most often reduce purchase price?
Five: multi-state licensure gaps (especially conditional statuses or unresolved corrective action plans not disclosed in the CIM), Medicaid contract durability (rate methodology changes, procurement re-bids, timely filing exposure), payer concentration above 20% with a single MCO in any state (relevant because KFF reports five firms account for 50% of Medicaid MCO enrollment nationally), MHPAEA NQTL exposure (the statutory obligation under CAA 2021 remains in force even after the DOL/HHS/Treasury May 15, 2025 non-enforcement statement on the 2024 final rule), and compliance program maturity across 42 CFR Part 2, HIPAA, and any active SIU audit. Sellers who miss any of these accept escrows north of 15% of consideration or take a price cut.
How much lead time does a Medicaid-heavy platform need before a sale process?
Eighteen to twenty-four months. A licensure stack, contract abstract library, current NQTL comparative analysis, and 24-month chart audit trend line cannot be assembled in a 90-day data room sprint. Sellers who start early defend valuation; sellers who start late renegotiate it.
Why is Medicaid fraud enforcement history now a diligence checkpoint?
Because enforcement is aggressive and public. Per the Arizona AG’s office, behavioral health billing in the American Indian Health Plan fell from approximately $3.1 billion (2021-2023) to about $229.9 million (2024-2026), a 92% decline, after AG Kris Mayes launched her crackdown in 2023. Federally, DOJ’s 2025 National Health Care Fraud Takedown charged 324 defendants across 50 federal districts in connection with over $14.6 billion in intended loss, more than doubling the prior record, and the government seized over $245 million in assets. Buyers now underwrite the absence of fraud-adjacent risk before they underwrite growth.
References
- Molina Healthcare: Agreement to Sell Pathways Health and Community Support to Atar Capital (Oct. 22, 2018)
- Axios Pro: Atar Capital selling behavioral health provider Clarvida (May 7, 2026)
- Behavioral Health Business: Atar Capital Reportedly Selling Outpatient Provider Clarvida (May 11, 2026)
- KFF: A Closer Look at the Five Largest Publicly Traded Companies Operating Medicaid Managed Care Plans
- U.S. Departments of Labor, HHS, and Treasury: MHPAEA 2024 Final Rule Non-Enforcement Statement (May 15, 2025)
- Arizona Attorney General’s Office: AG Mayes Announces Behavioral Health Fraud Sentence and 92% Billing Decline (May 14, 2026)
- U.S. Department of Justice: 2025 National Health Care Fraud Takedown (June 30, 2025)
- Groom Law Group: Departments Pause Enforcement of MHPAEA Final Rule